STAT+: Longevity, wellness physicians named to panel advising FDA on peptides

The FDA announced eight new panelists to advise on regulations for compounding pharmacies manufacturing peptides. Most panelists are linked to businesses promoting peptides, and one, Bobby Harshbarger, is a pharmacist and Tennessee state senator. A professor raised concerns about the panelists' ties to unproven peptide and stem cell treatments.